Phreesia Cash on Hand 2019-2025 | PHR

Phreesia cash on hand from 2019 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Phreesia Annual Cash on Hand
(Millions of US $)
2025 $84
2024 $88
2023 $177
2022 $314
2021 $219
2020 $90
2019 $2
2018 $0
Phreesia Quarterly Cash on Hand
(Millions of US $)
2025-01-31 $84
2024-10-31 $82
2024-07-31 $82
2024-04-30 $80
2024-01-31 $88
2023-10-31 $103
2023-07-31 $128
2023-04-30 $150
2023-01-31 $177
2022-10-31 $210
2022-07-31 $241
2022-04-30 $269
2022-01-31 $314
2021-10-31 $400
2021-07-31 $440
2021-04-30 $451
2021-01-31 $219
2020-10-31 $254
2020-07-31 $84
2020-04-30 $90
2020-01-31 $90
2019-10-31 $91
2019-07-31 $100
2019-04-30
2019-01-31
2018-10-31
2018-07-31
2018-01-31
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.431B $0.420B
Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based in New York.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $37.908B 52.36
Hims & Hers Health (HIMS) United States $12.273B 127.51
Tempus AI (TEM) United States $10.774B 0.00
IRhythm Technologies (IRTC) United States $4.555B 0.00
Inspire Medical Systems (INSP) United States $4.224B 66.00
Privia Health (PRVA) United States $2.787B 190.50
Enovis (ENOV) United States $1.803B 10.05
Clover Health Investments (CLOV) United States $1.623B 0.00
Schrodinger (SDGR) United States $1.563B 0.00
Omnicell (OMCL) United States $1.322B 23.33
Azenta (AZTA) United States $1.236B 57.45
10x Genomics (TXG) United States $1.006B 0.00
Fulgent Genetics (FLGT) United States $0.618B 0.00
Butterfly Network (BFLY) United States $0.537B 0.00
Veradigm (MDRX) United States $0.476B 0.00
Talkspace (TALK) United States $0.472B 141.00
Claritev (CTEV) United States $0.437B 0.00
TruBridge (TBRG) United States $0.357B 791.00
Standard BioTools (LAB) United States $0.350B 0.00
Outset Medical (OM) United States $0.318B 0.00
Nyxoah SA (NYXH) Belgium $0.264B 0.00
Health Catalyst (HCAT) United States $0.254B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.190B 0.00
EUDA Health Holdings (EUDA) Singapore $0.140B 0.00
Pulmonx (LUNG) United States $0.125B 0.00
American Well (AMWL) United States $0.116B 0.00
MDxHealth SA (MDXH) Belgium $0.096B 0.00
CareCloud (CCLD) United States $0.084B 3.21
111 (YI) China $0.069B 0.00
HeartBeam (BEAT) United States $0.056B 0.00
P3 Health Partners (PIII) United States $0.052B 0.00
Zepp Health (ZEPP) Netherlands $0.037B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.026B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
Precipio (PRPO) United States $0.015B 0.00
MSP Recovery (MSPR) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Streamline Health Solutions (STRM) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.009B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Movano (MOVE) United States $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00